Pharma

Your Article Summary

See Latest Articles

Insulin detemir alert issued by FDA
American Pharmacists Association, 06/15/09

FDA announced that some stolen vials of the basal insulin product Levemir have reappeared and are being sold on the U.S. market. Pharmacists should remove vials with the following lot numbers of this insulin detemir product from inventory: XZF0036, XZF0037, and XZF0038. One report of a patient who suffered an adverse event due to poor control of glucose levels after using a vial from one of these three lots has been reported to FDA.

Today in Regulatory Issues...keeping you current

Receive free subspecialty "5-minute updates" via email

Retigabine Regulatory Update
GlaxoSmithKline, 11/03/09

Review calls for EHR action in Saskatchewan
Canadian Healthcare Technology, 11/20/09

New Drug Application Filed for Eldecalcitol, An Active Vitamin D3 Derivative
Chugai Pharmaceutical Co., 11/04/09

See All of Regulatory Issues